Antibiotic Developments Insights
The panel combatting the rise of antibiotic resistance in UTIs
Rebekah Jordan sits down with Oliver Schacht, CEO of OpGen, to discuss the increasing prevalence of antibiotic resistance in Urinary Tract Infections (UTIs), and how OpGen’s Unyvero can quicken the AR diagnosis process. Read more
11 Aug 2022
Antimicrobial resistance: Here we go again
Why we should pay attention to the latest antimicrobial resistance research. Read more
17 Feb 2022
The future of combatting antimicrobial resistance
Oliver Schacht, CEO of OpGen looks at why technologies including artificial intelligence and machine learning could be key to combatting antimicrobial resistance. Read more
29 Nov 2021
AMR in Orthopedics – Benefits of topical treatment and latest advances
Michael Harris, chief executive officer of Biocomposites explores the threat of antibiotic resistance and how antibiotics are being used within the orthopaedics industry. Read more
7 Oct 2021
Improving our approach to fighting AMR
Oliver Schacht, CEO of precision medicine and genomics analysis company OpGen explores what we need to do to improve our fight against antimicrobial resistance (AMR). Read more
11 Aug 2021
The state of bioinformatics in the fight against AMR
Oliver Schacht, CEO of OpGen, Inc., examines the potential of bioinformatics in helping to fight antimicrobial resistance. Read more
27 Jan 2021
Global study shows cefiderocol’s success in treating resistant infections
Shionogi & Co., Ltd. shared new data at IDWeek 2024 from the PROVE study, the largest global real-world evidence review of Fetroja/Fetcroja (cefiderocol). Read more
17 Oct 2024
WHO Report Shows Increase in HIV Drug Resistance to Dolutegravir
The World Health Organization’s (WHO) latest HIV Drug Resistance (HIVDR) Report tells us where drug resistance is growing and offers recommendations for countries to monitor and respond to the potential challenges. Read more
8 Mar 2024
SIRIO Launches New Consumer Health Gummies at CPHI Barcelona
Sirio Pharma will further expand its offering in the consumer health market, building on last month’s ‘pharma targeted’ softgel launch, with the introduction of a range of herbal gummies for trending consumer health categories. Read more
6 Oct 2023
Why Pharmaceutical Industry Needs a Digital Content Factory (DCF)?
Modern pharma brands pursue a higher degree of content personalisation to engage with diverse audiences. This means tighter deadlines, higher workloads, and a greater demand for skilled content creators than ever before. Read more
Signposting the route to sustainable devices with life-cycle assessment
Alex Fong, insights and sustainability lead, Owen Mumford, addresses the environmental impact of single-use drug delivery devices and emphasises the role of life-cycle assessment (LCA) in sustainable design. Read more
18 Nov 2024
Futureproofing medicines manufacturing with virtual solutions
Editor Rebekah Jordan speaks to Ivan Wall, a professor at the University of Birmingham and co-director of the Resilience project, to learn about the advancements the initiative is making in UK medicines manufacturing. Read more
15 Nov 2024
Three essential tips for stability partner selection
Broughton highlights the top three tips in choosing a stability partner and explains how its extensive expertise positions it as a leader in stability testing. Read more
12 Nov 2024
Trends shaping collaborations in drug development and manufacturing
Given the success of nasal drug-delivery products relies on balancing formulation and device selection, Eric Kaneps at Renaissance Lakewood, LLC explains the importance of partnerships and collaborations drug development and manufacturing. Read more
8 Nov 2024
Biometric ID drives security and efficiency in pharma manufacturing
Paul Shu of ARISTA Corporation, explains how pharma manufacturers are increasingly turning to wearable biometric ID products to securely speed authentication in a hands-free manner. Read more
18 Oct 2024
How can you use content to achieve goals beyond the usual scope?
Nataliya Andreychuk, CEO and co-founder of Viseven, explores how to leverage content in pharma beyond traditional marketing goals, highlighting customer education, societal influence, product development and policy impact. Read more
15 Oct 2024
Sponsored Content
Why Pharmaceutical Industry Needs a Digital Content Factory (DCF)?
Modern pharma brands pursue a higher degree of content personalisation to engage with diverse audiences. This means tighter deadlines, higher workloads, and a greater demand for skilled content creators than ever before. Read more